PECAM1 and neoplasm: Similarly, co-staining of CD31 or CD10 with FvWhs showed that tumors cells expressing endothelial markers were detectable in 786– 0 tumors, absent in tumors that responded to sunitinib therapy and present at the time of tumor progression (Figure 3G).